4.7 Review

miR-134: A Human Cancer Suppressor?

Journal

MOLECULAR THERAPY-NUCLEIC ACIDS
Volume 6, Issue -, Pages 140-149

Publisher

CELL PRESS
DOI: 10.1016/j.omtn.2016.11.003

Keywords

-

Funding

  1. National Natural Science Foundation of China [81271943, 81360447, 81372973]
  2. Scientific and Technological Innovation Team of High-tech Industries of Wuhan Municipal Science and Technology Bureau [2015070504020219]
  3. Fundamental Research Funds for the Central Universities [2015305020202]

Ask authors/readers for more resources

NMicroRNAs (miRNAs) are small noncoding RNAs approximately 20-25 nt in length, which play crucial roles through directly binding to corresponding 30 UTR of targeted mRNAs. It has been reported that miRNAs are involved in numerous of diseases, including cancers. Recently, miR-134 has been identified to dysregulate in handles of human cancers, such as lung cancer, glioma, breast cancer, colorectal cancer, and so on. Increasing evidence indicates that miR-134 is essential for human carcinoma and participates in tumor cell proliferation, apoptosis, invasion and metastasis, drug resistance, as well as cancer diagnosis, treatment, and prognosis. Nevertheless, its roles in human cancer are still ambiguous, and its mechanisms are sophisticated as well, referring to a variety of targets and signal pathways, such as STAT5B, KRAS, MAPK/ERK signal pathway, Notch pathway, etc. Herein, we review the crucial roles of miR-134 in scores of human cancers via analyzing latest investigations, which might provide evidence for cancer diagnose, treatment, prognosis, or further investigations.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available